Zacks Investment Research Downgrades Smiths Group PLC (SMGZY) to Sell
Smiths Group PLC (NASDAQ:SMGZY) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a research note issued to investors on Thursday.
According to Zacks, “Smiths Group plc is a technology company. The Company designs, manufactures and delivers products and services for the threat & contraband detection, medical devices, energy and communications market. Its operating segment consists John Crane sector provides mechanical seals, seal support systems, engineered bearings, power transmission couplings and specialist filtration systems, Smiths Medical sector provides infusion systems, vascular access, patient airway and temperature management equipment and specialty devices. Smiths Detection sector provides sensors that detect and identify explosives, narcotics, weapons, chemical agents, biohazards and contraband; Smiths Interconnect sector provides specialised electronic and radio frequency components and sub-systems that connect, protect and control critical systems; Flex-Tek division provides engineered components that heat and move fluids and gases, flexible hosing and rigid tubing. Smiths Group plc is headquartered in London, the United Kingdom. “
Shares of Smiths Group PLC (NASDAQ:SMGZY) opened at 21.68 on Thursday. The firm has a market cap of $8.57 billion and a PE ratio of 11.71. Smiths Group PLC has a 12 month low of $17.09 and a 12 month high of $22.33. The stock’s 50 day moving average is $21.17 and its 200 day moving average is $21.04.
About Smiths Group PLC
Smiths Group plc is a technology company. The Company operates in five divisions: John Crane, Smiths Medical, Smiths Detection, Smiths Interconnect and Flex-Tek. The John Crane division offers mechanical seals, seal support systems, engineered bearings and power transmission couplings, among others. The Smiths Medical division offers infusion systems, vascular access (including safety needles), patient airway and temperature management equipment, and specialty devices in areas of in vitro fertilization, diagnostics and emergency patient transport.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Smiths Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smiths Group PLC and related companies with MarketBeat.com's FREE daily email newsletter.